Home Luteinizing Hormone Ovulation Test Cassette

For the qualitative detection of Human chronic gonadotropin in urine

LH Rapid Test Kit Home Use Luteinizing Hormone Ovulation Predictor For Women Pregnancy

Intended Use

Home Ovulation Test Midstream is an in vitro diagnostic (IVD) qualitative test for rapid detection of human luteinizing hormone (LH) in urine at a sensitivity of 20mIU/ml.

Principle

Home Ovulation Test Midstream is a qualitative, two site sandwich immunoassay for the determination of human luteinizing hormone (LH) in urine specimens. The membrane was precoated with LH specific antibodies on the test region.

During the test, the specimen is allowed to react with the LH monoclonal antibody-colloid gold conjugate, which was pre-dried on the test strip. The mixture then moves upward on the membrane chromatographically by the capillary action. For a positive specimen, the conjugate binds to the LH forming an antibody-antigen complex.

This complex binds to the LH antibody as a capture regent on the test region and produces a colored band when LH concentration is equal to or greater than 20mIU/ml.

The Home Ovulation Test Midstream also provides a built-in process control. A colored band should always appear in the Control Region, regardless of the presence of any urinary LH.

This control band verifies that 1) sufficient urine volume was added 2) proper urine flow was obtained 3) the test is functioning correctly. The absence of a control band may indicate the test was not performed correctly or that the test did not function correctly.

Assay Procedure

1. Remove the midstream test device from pouch by tearing.
2. Take off the clear cap from sample end of device and put it to other end of device to cover window area.
3. Hold the end of cap and put the urine holes in urinating stream for 3-5 seconds.
4. Re-cap the device and lay it on flat surface.
5. Wait for 10-15 minutes to read result. Do not try to interpret results after 15 minutes.

Interpretation of Results

Negative:

Only one colored band appears on the control region (C). No colored band in the test region (T).

Positive:

In addition to the control band (C), a distinct colored band also appears in the test region (T).

Invalid:

If no bands appear, or a test band appears without a control band, the test should be repeated using a new test Midstream.

Newscen Biopharm Co., Limited is a professional manufacturer of in vitro diagnostic products and related supporting apparatuses, which is jointly founded by Tianjin Pharmaceutical Group, Tianjin Zhongxin Pharmaceuticals Co., Ltd and oversea Chinese entrepreneurs.

Founded in 2003, the company is one national high tech corporation and Tianjin Grade A medical device manufacturer. Over the years, the company has been committed to the research, development, production and sales of in vitro diagnostic products and related supporting apparatuses, and also has provided OEM and ODM and technology transfer and cooperation as well as some other customer market based diversified services to customers at home and abroad.

NewScen is based on independent innovation and relies on the talent sharing at home and abroad, information interaction advantage, antibody preparation and new product R & D technology platform to develop and produce nine series about one hundred kinds of products including tests and instruments and put on the market in succession.

HIV (1 + 2) antibody rapid test Kit and other IVD (In Vitro Diagnostic) devices obtained National Patent and National Class of New Drug Certificate; HCV Antibody Rapid Test is the first double antigen sandwich test HCV patented product; NewScen’s quantitative test broke through the technical difficulty of the colloid gold quantitative detection, opening up a new situation for clinical application of Colloidal Gold test. Rapid immuno assay reader provides an open and common platform for qualitative and quantitative detection of the Colloidal Gold test.

The company has received CFDA medical device certificates of 32 products, 49 independent Intellectual Property Rights, FDA certificates of series of products and European CE certificates of 16 products. Production management is in strict accordance with the regulations of in vitro diagnostic product production as well as international quality management system (ISO 9001, ISO 13485) so as to ensure high product quality. Products are sold throughout the country and in North America, South America, Southeast Asia, Europe, the Middle East, Africa and other international markets.

Currently, the company integrated Colloidal Gold test, immunochromatographic interpretoscope and cloud technology and other technical advantages, and created management integrated POCT system, so as to achieve convenient, accurate and efficient onsite data collection and remote guidance or data sharing of the monitoring center and promote the development of modern testing technique and the improvement of diagnosis and treatment level.

NewScen has obtained the project support from Tianjin or the country for nine times in succession, has been identified as one Hightech Enterprise in Tianjin, has obtained the title of “Top 100 Enterprise in Tianjin” among Tianjin SMEs, and is the rapid diagnostic Hightech demonstration project base and National 863 Project undertaker awarded by the NDRC (National Development and Reform Commission).

Fecal Occult Blood, Serum Ferritin and Hepatitis C rapid test products were named Tianjin independent innovation products; brand “YBT”products have been awarded the title of “Chinese Women and Children Favorite Brand Product” by Chinese Women and Children Development Center; “YBT” trademark was named “Tianjin Famous Trademark”.

“Honesty, Verity, Authenticity, and Innovation", is our persistent commitment.

“Encouraging Our Employees Growing With Company” is the driving force beneath our surging growth.